Moscow Research Oncology Institute n.a. P.A.Gertsen

Moscow 125284

0 studies enrolling now · 2 studies all time

What they study most

Ovarian Cancer, Prostate Cancer Metastatic

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed